发明名称 Sertraline salts and sustained-release dosage forms of sertraline
摘要 Sustained release dosage forms of sertraline, or pharmaceutically acceptable salts thereof are disclosed. Sertraline is released at a rate of between 0.02 mgA/hr/kg and 0.6 mgA/hr/kg, or between 1 mgA/hr and 40 mgA/hr, where mgA is the amount of active sertraline. The dosage form must not release more than 70% of the sertraline in the first hour following administration. The dosage form is suitable for oral administration to a mammal.
申请公布号 NZ501251(A) 申请公布日期 2001.09.28
申请号 NZ19980501251 申请日期 1998.06.15
申请人 PFIZER INC 发明人 FRIESEN, DWAYNE THOMAS;WEST, JAMES BLAIR;HERBIG, SCOTT MAX;AM ENDE, MARY TANYA;CURATOLO, WILLIAM JOHN;FRIEDMAN, HYLAR LEWIS;SHANKER, RAVI MYSORE
分类号 A61K9/22;A61K;A61K9/00;A61K9/16;A61K9/20;A61K9/26;A61K9/28;A61K9/32;A61K9/50;A61K9/52;A61K9/54;A61K31/135;A61P3/04;A61P25/18;A61P25/24;A61P25/30;C07C209/00;C07C211/42;C07D;(IPC1-7):A61K31/135 主分类号 A61K9/22
代理机构 代理人
主权项
地址